Industry Innovator and Rheologics Founder to Speak on the Importance of Measuring Blood Flow at...

Business Editors/Health & Medical Writers

EXTON, Pa.--(BW HealthWire)--Nov. 7, 2001

Kenneth R. Kensey, M.D. to Present Evidence that the Treatment and

Prevention of High Blood Viscosity Dramatically

Reduces the Risk of Cardiovascular Disease

Rheologics, Inc. (formerly Visco Technologies), a pioneer in the prevention and treatment of heart disease and stroke today announced that its founder and chief executive officer Kenneth R. Kensey, M.D. will be a featured speaker at the 2001 Information Handling Services Health Group's New Advances in Cardiology and Vascular Therapies conference being held November 12 in Anaheim, Calif. As part of the program focused on emerging trends in cardiology, Dr. Kensey will discuss the growing evidence that increased blood viscosity initiates heart disease. In addition, Dr. Kensey will highlight methods for detection and prevention of atherosclerosis. He is scheduled to speak at 1:45 p.m. in the Trillium Room at Disney's Grand Californian Resort.

The New Advances in Cardiology and Vascular Therapies conference, presented by the IHS Health Group, addresses new directions and long-term market opportunities within the industry. Specifically, the program focuses on emerging trends in interventional cardiology, restenosis prevention, arrhythmia management and endovascular technology.

About Dr. Kenneth R. Kensey

Kenneth R. Kensey, M.D., president and chief executive officer, is a pioneer and recognized leader in cardiovascular product development. Prior to founding Rheologics in 1997, he co-founded Kensey Nash Corporation (Nasdaq:KNSY), where his impressive track record of achievement included the development of products such as the Kensey Catheter(TM) for Dynamic Angioplasty and the AngioSeal(TM). He is the author of The Blood Thinner Cure: A Revolutionary Seven Step Lifestyle Plan for Stopping Heart Disease and Stroke, and a second book to be released in late 2001. Additionally, his scientific papers on blood viscosity have appeared in publications such as the Journal of Invasive Cardiology and the Review of Scientific Instruments. A frequent guest speaker at universities such as Harvard and Stanford, Dr. Kensey has lectured throughout Europe and Asia on radiologic, cardiologic and surgical techniques.

About Rheologics, Inc.

Since 1997, Rheologics, Inc. (formerly known as Visco Technologies) has pioneered a new standard of care in the prevention and treatment of heart disease and stroke. Supplementing the existing understanding of the risk factors for these diseases, Rheologics' mission is to complete the picture by focusing on the emerging field of hemorrheology -- the study of the dynamics of blood flow and its impact on vascular-related diseases. Rheologics is headquartered in Exton, Pennsylvania. For more information, please call 800/969-2585 or visit the company web site at www.rheologics.com.